Not Medicare Enrolled

Dr. Lori Grabois, M.D.

Psychiatry · Aventura, FL
21110 BISCAYNE BLVD, Aventura, FL 33180
3059325500
Registered in NPPES since 2006
NPI: 1952380933 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Grabois from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Grabois? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Grabois

Dr. Lori Grabois is a psychiatry specialist in Aventura, FL, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Grabois received a total of $12,627 from 32 pharmaceutical and/or device companies across 582 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Grabois is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $12,627 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 47987 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$12,627
Total received (2018-2024)
Avg $1,804/year across 7 years
Top 7% in FL for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
582
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,714
2023
$2,095
2022
$2,600
2021
$2,185
2020
$1,221
2019
$1,239
2018
$1,573

Payments by company (2024)

ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$352
Otsuka America Pharmaceutical, Inc.
$281
Axsome Therapeutics, Inc.
$224
Lundbeck LLC
$193
Janssen Pharmaceuticals, Inc
$143
Almatica Pharma LLC
$125
E.R. Squibb & Sons, L.L.C.
$119
Bausch Health US, LLC
$93
Neurocrine Biosciences, Inc.
$70
Takeda Pharmaceuticals U.S.A., Inc.
$54
Supernus Pharmaceuticals, Inc.
$36
Noven Therapeutics, LLC
$24
Top 3 companies account for 50.0% of 2024 payments
All-time payments by company (2018-2024) ›
Lundbeck LLC
$1,422
Otsuka America Pharmaceutical, Inc.
$1,193
Vanda Pharmaceuticals Inc.
$1,031
ITI, Inc.
$1,010
Janssen Pharmaceuticals, Inc
$928
Teva Pharmaceuticals USA, Inc.
$834
Takeda Pharmaceuticals U.S.A., Inc.
$650
Allergan Inc.
$541
Axsome Therapeutics, Inc.
$534
Bausch Health US, LLC
$533
ABBVIE INC.
$454
Avanir Pharmaceuticals, Inc.
$393
Neurocrine Biosciences, Inc.
$389
AbbVie Inc.
$361
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$352
Allergan, Inc.
$350
Alkermes, Inc.
$300
Sunovion Pharmaceuticals Inc.
$289
Shire North American Group Inc
$227
Almatica Pharma LLC
$204
E.R. Squibb & Sons, L.L.C.
$119
Tris Pharma Inc
$118
Adlon Therapeutics L.P.
$78
IDORSIA PHARMACEUTICALS US INC
$69
DySIS Medical, Inc.
$55
Ironshore Pharmaceuticals Inc.
$39
Supernus Pharmaceuticals, Inc.
$36
Alfasigma USA, Inc.
$33
Noven Therapeutics, LLC
$24
LivaNova USA, Inc.
$21
Corium, LLC
$20
Eisai Inc.
$19
Top 3 companies account for 28.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Austedo XR · Auvelity · BRINTELLIX · CAPLYTA · COBENFY · Dayvigo · Dyanavel XR · FANAPT · Fanapt · GRALISE · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · MYDAYIS · NUEDEXTA · ONGENTYS · QUVIVIQ · Qelbree · REXULTI · SPRAVATO · TRINTELLIX · Trintellix · Ultra 2.0 · VIIBRYD · VNS - Symmetry · VRAYLAR · VYVANSE · WELLBUTRIN · Xelstrym
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Aventura?
Compare psychiatrists in the Aventura area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
618
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA AVENTURA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Grabois is a psychiatry specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Grabois receive payments from pharmaceutical companies?
Yes. Dr. Grabois received a total of $12,627 from 32 companies across 582 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Grabois) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →